Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Keyphrases
Analysis Prior
20%
Antibiotic Choices
40%
Antibiotic Prescription
100%
Antibiotics
60%
Antipseudomonal
80%
Antipseudomonal Antibiotics
100%
Carbapenems
20%
Cefepime
20%
Clinical Data
20%
Clinical Practice
20%
Community-acquired Pneumonia
20%
Demographic Data
20%
Disease Severity
20%
Emergency Department
100%
Empiric Antibiotics
20%
Hospitalization
40%
Hospitalized Adults
20%
ICU Admission
60%
Lactams
20%
Levofloxacin
60%
Low Incidence
20%
Monotherapy
40%
Multilobar
20%
Negatively Associated
20%
Non-associated
20%
P. Aeruginosa Infection
40%
Patients at Risk
20%
Piperacillin-tazobactam
20%
Pneumonia
100%
Pseudomonas Aeruginosa (P. aeruginosa)
100%
Pseudomonas Aeruginosa Infection
20%
Quinolones
20%
Reliable Indicator
20%
Severe COPD
40%
Univariate Analysis
20%
Urinary Antigen Test
40%
Medicine and Dentistry
Antibiotics
42%
Carbapenem Derivative
14%
Cefepime
14%
Chronic Obstructive Pulmonary Disease
28%
Cohort Analysis
14%
Community-Acquired Pneumonia
14%
Diseases
14%
Emergency Department
100%
Infection
28%
Lactam
14%
Levofloxacin
42%
Monotherapy
28%
Piperacillin/Tazobactam
14%
Prevalence
14%
Pseudomonas aeruginosa
100%
Pseudomonas Infection
14%
Quinolone Derivative
14%
Univariate Analysis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotics
42%
Carbapenem Derivative
14%
Cefepime
14%
Chronic Obstructive Lung Disease
28%
Cohort Study
14%
Community Acquired Pneumonia
14%
Diseases
14%
Infection
28%
Lactam
14%
Levofloxacin
42%
Monotherapy
28%
Piperacillin Plus Tazobactam
14%
Prevalence
14%
Pseudomonas aeruginosa
100%
Pseudomonas Infection
14%
Quinolone Derivative
14%